CN Mobile Logo

Search form


Mark L. Fuerst

Mark L. Fuerst

Mark L. Fuerst is a freelance health and medical writer for ConsultantLive, Rheumatology Network, Psychiatric Times, and other UBM publications. He writes about rheumatology, psychiatry, neurology, endocrinology, oncology, and men’s health.

Posts by Author

Both oncologists and cancer patients recognize the benefits of physical activity during treatment, but oncologists may feel ill-equipped to give recommendations on exercise, according to a new study.

Adding selumetinib to docetaxel does not provide any significant benefit over docetaxel alone for patients previously treated for advanced KRAS-mutant non–small-cell lung cancer.

©Sean K/Shutterstock.com

Antiretroviral therapy has dramatically reduced AIDS-associated morbidity and mortality -- but only in those who know they are HIV positive and if they maintain sustained engagement with care.

May is Asthma Awareness Month and so a look at new studies highlighting key aspects of management is in order.

A noninvasive PET imaging method may serve as a useful predictive biomarker for responses to cancer immunotherapy, according to a new study.

Prescribing has gone from underuse to substantial overprescribing. The challenge is to get it just right.

Cytomegalovirus targeted vaccination plus high-dose chemotherapy with temozolomide can lead to long-term progression-free and overall survival in patients with newly diagnosed glioblastoma.

A nivolumab/ipilimumab combination significantly improved overall survival for advanced melanoma patients.

©Puwadol Jaturawutthichai/Shutterstock.com

The paradigm of HIV care is changing for aging patients. This study sheds new light.

Young men who are overweight or obese are at risk of developing severe liver disease or liver cancer in later life, particularly those who have type 2 diabetes mellitus.


By clicking Accept, you agree to become a member of the UBM Medica Community.